| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to medicine, in particular to ophthalmology. An agent is applicable for a cross-linking procedure accompanying corneal ectasias. The agent contains riboflavin mononucleotide, chitosan succinate, sodium chloride, tris-(hydroxymethyl)-methylamine, Nipagin, disodium dihydrogen ethylenediaminetetraacetate and purified distilled water in certain proportions.EFFECT: invention provides prolonged action of the agent, improves bacteriological availability for active ingredients, reduces the length and number of instillations for the procedure, provides agent saving.1 ex |
